Cashmere Karen A. 4
4 · ZyVersa Therapeutics, Inc. · Filed Jul 16, 2025
Insider Transaction Report
Form 4
Cashmere Karen A.
Chief Commercial Officer
Transactions
- Award
Stock Options
2025-07-11+48,100→ 48,100 totalExercise: $0.59Exp: 2035-07-11→ Common Stock (48,100 underlying)
Footnotes (2)
- [F1]This Form 4 is being filed late as the result of an inadvertent administrative oversight.
- [F2]The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.